Thromboxane synthetase inhibition as a new therapy for preeclampsia: animal and human studies minireview.
The role of the eicosanoids in the pathophysiology of preeclampsia is reviewed, and the results of animal model and human studies with thromboxane synthetase inhibitors in preeclampsia are described. Potential benefits and limitations of therapy are discussed.